Association ofHMGB1andHMGB2genetic polymorphisms with lung cancer chemotherapy response (Q57500224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Ying Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Xiang-Ping Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yu Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hui He

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Chen-Yue Qian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Juan Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yi Zheng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Kamila Smieszkol

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yi-Lan Fu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Zi-Yu Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hong-Hao Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

1 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Pharmacology and Physiology

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

408-415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Multidisciplinary management of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Understanding cisplatin resistance using cellular models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

The resurgence of platinum-based cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Molecular mechanisms of platinum resistance: still searching for the Achilles' heel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Mechanisms of resistance to cisplatin and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Pharmacogenetics for individualized cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

HMGB1 in cancer: good, bad, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Enhancement of cisplatin sensitivity in high mobility group 2 cDNA-transfected human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

High-mobility group box 1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

HMGB1 and RAGE in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

HMGB1: the jack-of-all-trades protein is a master DNA repair mechanic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

HMGB proteins and transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Dual roles for HMGB1: DNA binding and cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

High mobility group protein-1 (HMG-1) is a unique activator of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Interactions between an HMG-1 protein and members of the Rel family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Growth suppression and radiosensitivity increase by HMGB1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

The plasticity of estrogen receptor-DNA complexes: binding affinity and specificity of estrogen receptors to estrogen response element half-sites separated by variant spacers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

The genetic variation of the human HMGB1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

The human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

A survey of 178 NF-Y binding CCAAT boxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

The human cut homeodomain protein can repress gene expression by two distinct mechanisms: active repression and competition for binding site occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Viral myb oncogene encodes a sequence-specific DNA-binding activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

HMGB1 gene polymorphisms in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

21 January 2018

Small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Integrating common and rare genetic variation in diverse human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

The International HapMap Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12232

21 January 2018

Identifiers

DOI

10.1111/1440-1681.12232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24684392%20AND%20SRC:MED&resulttype=core&format=json